A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
- 21 October 2010
- Vol. 28 (45) , 7337-7343
- https://doi.org/10.1016/j.vaccine.2010.08.073
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trialVaccine, 2010
- Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and ChildrenJAMA, 2010
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trialsThe Lancet, 2010
- Seasonal Influenza Vaccine Provides Priming for A/H1N1 ImmunizationScience Translational Medicine, 2009
- A Novel Influenza A (H1N1) Vaccine in Various Age GroupsNew England Journal of Medicine, 2009
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccineVaccine, 2008
- Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007–2008Pediatrics, 2008